Old Web
English
Sign In
Acemap
>
authorDetail
>
Katie Quinlan
Katie Quinlan
Johns Hopkins University
Physical therapy
Aromatase inhibitor
Clinical trial
Discontinuation
Zoledronic acid
2
Papers
6
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial
2018
Breast Cancer Research and Treatment
Cesar A. Santa-Maria
Aditya Bardia
Amanda Blackford
Claire F. Snyder
Roisin M. Connolly
John H. Fetting
Daniel F. Hayes
Stacie Jeter
Robert S. Miller
Anne Nguyen
Katie Quinlan
Gary L. Rosner
Shannon Slater
Anna Maria Storniolo
Antonio C. Wolff
Jane Zorzi
Nora Lynn Henry
Vered Stearns
Show All
Source
Cite
Save
Citations (5)
A phase II study evaluating efficacy of zoledronic acid in prevention of aromatase inhibitor (AI)-associated musculoskeletal symptoms: The ZAP trial.
2014
Journal of Clinical Oncology
Cesar Augusto Santa-Maria
Aditya Bardia
Amanda Blackford
Roisin M. Connolly
John H. Fetting
Stacie Jeter
Robert S. Miller
Anne T. Nguyen
Katie Quinlan
Shannon Slater
Claire Frances Snyder
Antonio C. Wolff
J. Zorzi
N. Lynn Henry
Vered Stearns
Show All
Source
Cite
Save
Citations (1)
1